3SBio Inc.
TRSBF
$0.7231
-$0.0121-1.65%
Weiss Ratings | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D+ | |||
Reward Grade | C | |||
Rating Factors | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Good | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -0.06 | |||
Price History | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -5.75% | |||
30-Day Total Return | -5.75% | |||
60-Day Total Return | -5.75% | |||
90-Day Total Return | -9.61% | |||
Year to Date Total Return | -9.61% | |||
1-Year Total Return | -9.61% | |||
2-Year Total Return | -9.61% | |||
3-Year Total Return | -9.61% | |||
5-Year Total Return | -50.13% | |||
52-Week High % Change | -5.75% | |||
52-Week Low % Change | 0.00% | |||
Price | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.77 | |||
52-Week Low Price | $0.72 | |||
52-Week Low Price (Date) | Sep 11, 2024 | |||
52-Week High Price (Date) | Jun 17, 2024 | |||
Valuation | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 1.70B | |||
Enterprise Value | 1.83B | |||
Price/Earnings (TTM) | 8.15 | |||
Earnings Per Share (TTM) | 0.09 | |||
Earnings Per Share Growth | -19.87% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 1.60 | |||
Price/Book (Q) | 0.88 | |||
Enterprise Value/Revenue (TTM) | 1.65 | |||
Price | $0.72 | |||
Enterprise Value/EBITDA (TTM) | 5.74 | |||
Enterprise Value/EBIT | 6.68 | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 2.44B | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | 14.12% | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 86 24 2538 6000 | |||
Address | -- | |||
Website | www.3sbio.com | |||
Country | China | |||
Year Founded | 1993 | |||
Profitability | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 24.73% | |||
Profit Margin | 19.94% | |||
Management Effectiveness | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 5.23% | |||
Return on Equity | 9.89% | |||
Income Statement | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 1.10B | |||
Total Revenue (TTM) | 1.10B | |||
Revenue Per Share | $0.45 | |||
Gross Profit (TTM) | 938.12M | |||
EBITDA (TTM) | 317.72M | |||
EBIT (TTM) | 273.15M | |||
Net Income (TTM) | 220.27M | |||
Net Income Avl. to Common (TTM) | 220.27M | |||
Total Revenue Growth (Q YOY) | 5.22% | |||
Earnings Growth (Q YOY) | -38.24% | |||
EPS Diluted (TTM) | 0.09 | |||
EPS Diluted Growth (Q YOY) | -38.31% | |||
Balance Sheet | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 845.04M | |||
Cash Per Share (Q) | $0.35 | |||
Total Current Assets (Q) | 1.30B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 2.33B | |||
Current Ratio (Q) | 2.466 | |||
Book Value Per Share (Q) | $0.83 | |||
Total Assets (Q) | 3.33B | |||
Total Current Liabilities (Q) | 525.69M | |||
Total Debt (Q) | 682.26M | |||
Total Liabilities (Q) | 1.00B | |||
Total Common Equity (Q) | 1.98B | |||
Cash Flow | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -194.65M | |||
Cash from Financing (TTM) | -48.24M | |||
Net Change in Cash (TTM) | 63.04M | |||
Levered Free Cash Flow (TTM) | 58.03M | |||
Cash from Operations (TTM) | 295.31M | |||